Literature DB >> 25482878

Why regenerative medicine needs an extracellular matrix.

Glenn D Prestwich1, Kevin E Healy.   

Abstract

Regenerative medicine is now coming of age. Many attempts at cell therapy have failed to show significant efficacy, and the umbrella term 'stem cell therapy' is perceived in some quarters as hype or just expensive and unnecessary medical tourism. Here we present a short editorial in three parts. First, we examine the importance of using a semisynthetic extracellular matrix (ECM) mimetic, or sECM, to deliver and retain therapeutic cells at the site of administration. Second, we describe one approach in which biophysical and biochemical properties are tailored to each tissue type, which we call "design for optimal functionality." Third, we describe an alternative approach to sECM design and implementation, called "design for simplicity," in which a deconstructed, minimalist sECM is employed and biology is allowed to perform the customization in situ. We opine that an sECM, whether minimal or instructive, is an essential contributor to improve the outcomes of cell-based therapies.

Entities:  

Keywords:  cell delivery; cell differentiation; cell retention; cell therapy; clinical biomaterial; extracellular matrix; regulatory barriers; stem-cell transplantation; tissue engineering; translational medicine

Mesh:

Substances:

Year:  2015        PMID: 25482878     DOI: 10.1517/14712598.2015.975200

Source DB:  PubMed          Journal:  Expert Opin Biol Ther        ISSN: 1471-2598            Impact factor:   4.388


  4 in total

1.  Tumor Resection Recruits Effector T Cells and Boosts Therapeutic Efficacy of Encapsulated Stem Cells Expressing IFNβ in Glioblastomas.

Authors:  Sung Hugh Choi; Daniel W Stuckey; Sara Pignatta; Clemens Reinshagen; Jasneet Kaur Khalsa; Nicolaas Roozendaal; Jordi Martinez-Quintanilla; Kaoru Tamura; Erhan Keles; Khalid Shah
Journal:  Clin Cancer Res       Date:  2017-09-14       Impact factor: 12.531

2.  A combined hiPSC-derived endothelial cell and in vitro microfluidic platform for assessing biomaterial-based angiogenesis.

Authors:  Sylvia L Natividad-Diaz; Shane Browne; Amit K Jha; Zhen Ma; Samir Hossainy; Yosuke K Kurokawa; Steven C George; Kevin E Healy
Journal:  Biomaterials       Date:  2018-11-28       Impact factor: 12.479

3.  Preliminary In Vitro Evaluation of Chitosan-Graphene Oxide Scaffolds on Osteoblastic Adhesion, Proliferation, and Early Differentiation.

Authors:  Sonia How Ming Wong; Siew Shee Lim; Timm Joyce Tiong; Pau Loke Show; Hayyiratul Fatimah Mohd Zaid; Hwei-San Loh
Journal:  Int J Mol Sci       Date:  2020-07-22       Impact factor: 5.923

Review 4.  Constructing a cell microenvironment with biomaterial scaffolds for stem cell therapy.

Authors:  Xiaotong Zhao; Qiong Li; Zhikun Guo; Zongjin Li
Journal:  Stem Cell Res Ther       Date:  2021-11-22       Impact factor: 8.079

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.